Tirzepatide combines the incretin effects of GLP-1 with GIP, the latter of which contributes to appetite regulation and further reductions in food intake
It deserves the same long-term, evidence-updated treatment thinking we apply to hypertension or diabetes
Settlements, as I am sure you know, do not admit liability, Belcher told Hunterbrook Media
When symptoms such as low energy, poor sleep, mood changes, low libido, or persistent weight gain are present, evaluating hormone health may provide additional insight into factors affecting weight management
If that makes you hesitate, youre not alone
The GLP-1 receptor agonists included dulaglutide (Trulicity, Eli Lilly), liraglutide (Saxenda, Novo Nordisk), exenatide (Bydureon, AstraZeneca), tirzepatide (Zepbound, Eli Lilly) and semaglutide